Search for Clinical Trial Results
Parainfluenza Virus Type 3 - 9 Studies Found
| Status | Study |
| Completed |
Study Name: Evaluating the Safety and Immunogenicity of a Human Parainfluenza Type 3 (HPIV3) Virus Vaccine in Infants and Children Condition: Parainfluenza Virus 3, Human Date: 2010-12-02 Interventions:
|
| Completed |
Study Name: A Study to Evaluate the Safety, Tolerability, Immunogenicity and Vaccine-like Viral Shedding of MEDI-534, Against Respiratory Syncytial Virus (RSV) and Parainfluenza Virus Type 3 (PIV3), in Healthy 6 to <24 Month-old Children and in 2 Month-old Infants Condition: Healthy Date: 2008-05-23 Interventions:
|
| Completed |
Study Name: Study to Evaluate the Safety of MEDI-534 Vaccine Against Respiratory Syncytial Virus (RSV) and Parainfluenza Virus Type 3 (PIV3) in Healthy Children Condition: Healthy Date: 2006-06-27 Interventions:
|
| Completed |
Study Name: Safety and Tolerability Study to Evaluate MEDI-534 in Children 6 to < 24 Months of Age Condition:
|
| Completed |
Study Name: Safety of and Immune Response to a Cow/Human Parainfluenza Virus Vaccine (rB/HPIV3) in Healthy Infants, Children, and Adults Condition:
Date: 2006-08-17 Interventions:
|
| Terminated |
Study Name: A Phase 1/2A Study to Evaluate the Safety, Immunogenicity, and Shedding of MEDI-560 in Infants 1 to < 12 Months of Age Condition: Healthy Date: 2007-07-27 Interventions:
|
| Completed |
Study Name: Safety of and Immune Response to Recombinant Live Attenuated Parainfluenza Type 3 Virus Vaccine in Healthy Infants and Children Condition:
Date: 2009-11-25 Interventions:
|
| Completed |
Study Name: Safety of and Immune Response to a Human Parainfluenza Virus Vaccine (rHPIV3cp45) in Healthy Infants Condition:
Date: 2006-03-28 Interventions:
|
| Completed |
Study Name: Study to Evaluate MEDI-534 in Healthy Adults Condition:
Date: 2005-05-26 Interventions: Drug: MEDI-534 |